Sonoma Pharmaceuticals (SNOA) Other Accumulated Expenses (2015 - 2025)

Sonoma Pharmaceuticals' Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $487000.0 for Q1 2025.

• In Q1 2025, Other Accumulated Expenses fell 29.83% year-over-year to $487000.0; the TTM figure through Mar 2025 stood at $487000.0 (down 29.83% YoY), while the FY2025 annual figure was $487000.0, down 29.83% from the prior year.
• Other Accumulated Expenses was $487000.0 for Q1 2025 at Sonoma Pharmaceuticals, down from $694000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $784000.0 in Q1 2022 to a low of $367000.0 in Q1 2021.
• Historically, Other Accumulated Expenses has averaged $579600.0 across 5 years, with a median of $566000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses soared 113.62% in 2022, then decreased 29.83% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $367000.0 in 2021, then jumped by 113.62% to $784000.0 in 2022, then decreased by 27.81% to $566000.0 in 2023, then rose by 22.61% to $694000.0 in 2024, then fell by 29.83% to $487000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $487000.0 (Q1 2025), $694000.0 (Q1 2024), and $566000.0 (Q1 2023), per Business Quant data.